Definitive Contract 75A50120C00142
Award Date 7/2/20
Potential Completion Date 11/1/20
Potential Value $9.3M
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Hoffman Estates, IL 60195, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award to Sagent Pharmaceuticals, Inc., a specialty and generic pharmaceutical manufacturer, by the Centers for Disease Control and Prevention (CDC) Pittsburgh. The award is a delivery order under an Indefinite Delivery/Indefinite Quantity (IDIQ) contract with a ceiling value of $19,362,816.00 and a firm fixed price pricing type. The contract is for the provision of injectable pharmaceutical products, including antibiotics, critical care medications, and anesthesia...
- This is a firm fixed price delivery order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh to Sagent Pharmaceuticals, Inc., a specialty pharmaceutical manufacturer. The $13,146,933.60 indefinite-delivery, indefinite-quantity (IDIQ) contract is for the delivery of injectable pharmaceutical products, including antibiotics and anesthesia drugs, to support military health care programs. The contract has a period of performance through...
- The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a firm fixed-price definitive contract to Pfizer Inc., a major pharmaceutical manufacturer, to procure pharmaceutical products including dopamine hydrochloride solution, methylprednisolone sodium succinate, and voriconazole tablets. The $735,306.20 contract has a completion date of February 29, 2024 and does not utilize any set-aside designations. This award was made under a...
- The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a 5-year Indefinite Delivery, Indefinite Quantity (IDIQ) contract to Hospira Worldwide LLC, a for-profit manufacturer of pharmaceuticals and medical supplies. The $915,595 contract is for firm-fixed-price delivery orders of sterile injectable drugs, antibiotics, anesthetics, and other pharmaceutical products. There was no set-aside designation for this award. Hospira Worldwide...
- This federal contract award, valued at $87,744.00, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Sagent Pharmaceuticals, Inc., a specialty pharmaceutical manufacturer. The award is for the delivery of Cefepime 2 gram solution for injections, a critical antibiotic medication used to support military healthcare programs and other federal medical needs. The contract is a delivery order under a larger $29.6 million single-award indefinite delivery/indefinite quantity...
- Sagent Pharmaceuticals, Inc. has been awarded a $576 delivery order against the Defense Logistics Agency Troop Support Medical's prime vendor pharmaceutical contract to supply 4561654155 CEFEPIME 2 GRAM SOLUTION FOR INJECTIONS. Performance will take place in Hoffman Estates, Illinois through August 3, 2023. The firm fixed price order was awarded on July 31, 2023 without a set-aside designation. Sagent Pharmaceuticals will deliver the requested cephalosporin antibiotic to support the Defense...
- The Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded a definitive contract to Phlow Corp. for US-based advanced API manufacturing of COVID-19 essential medicines and future medical countermeasures on May 18, 2020, with a ceiling value of $969.754 million. The contract operates under cost-plus-fixed-fee pricing with no set-aside. Place of performance is Richmond, VA. The originating solicitation was a Broad Agency Announcement...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to Sagent Pharmaceuticals, Inc., a specialty pharmaceutical manufacturer, for the supply of 4,558 units of Cefepime 2 gram solution for injections. The $145,984 delivery order was placed against an existing indefinite delivery/indefinite quantity contract with Sagent to provide injectable pharmaceutical products to support military healthcare programs. The award was not set aside for any special...
- The Office of the Assistant Secretary for Preparedness and Response (HHS ASPR) awarded an Other Transaction Agreement to On Demand Pharmaceuticals Inc. for $16,252,285 on June 1, 2024. The effort is a prototype for a distributed network to manufacture cisatracurium drug substance (API) and drug product under current Good Manufacturing Practice (CGMP) standards, with an ultimate completion date of May 19, 2026. Place of performance is Rockville, Maryland. The OTA operates outside the FAR...
- This is a firm fixed-price delivery order awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Pfizer Inc. for $2,151,230.00 to procure pharmaceuticals to replenish expired product. The order has an ultimate completion date of September 29, 2025 and was awarded on September 30, 2024. This delivery order is not associated with a set-aside program. Pfizer, a large pharmaceutical manufacturer, is the prime contractor and has provided pharmaceuticals,...
Sagent Pharmaceuticals, Inc. was awarded a $9.26 million firm fixed price definitive contract by the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response to supply propofol and rocuronium from July through November 2020. The contract supports the agency's efforts to respond to the Coronavirus Disease 2019 pandemic by providing needed pharmaceuticals to treat patients. Sagent Pharmaceuticals will deliver the drugs from its manufacturing facility in Hoffman Estates, Illinois. No subcontractors or set aside designations were identified. This contract augments HHS' strategic national stockpile and pandemic preparedness programs during the public health emergency.
Generated 12/25/23, 5:36 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Exercise an Option | $2.8m | 8/15/20 | |
| Not listed | Not listed | $6.5m | 7/6/20 |